The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)
Daniela Dornelles Rosa, José Bines, Gustavo Werutsky, Carlos Henrique Barrios, Eduardo Cronemberger, Geraldo Silva Queiroz, Vladmir C. Cordeiro de Lima, Rufo Freitas‑Júnior, José d’Oliveira Couto, Karla Emerenciano, Heloísa Resende, Susane Crocamo, Tomás Reinert, Brigitte Van Eyil, Yeni Nerón, Vanessa Dybal, Nicolas Lazaretti, Rita de Cassia Costamilan, Diocésio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Morelle, Maira Calef, Carlos Sampaio Filho, Max S. Mano, Facundo Zafaroni, Rafaela Gomes de Jesus, Sergio Daniel Simon - Breast Cancer Res Treat. 29 July 2020
De-escalation of Neoadjuvant Therapy for HER2-positive Early Breast Cancer: An Overview
Gustavo Werutsky, Mahira Lopes Rosa - Ann Palliat Med . 2020 July
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III
Alessandra Borba Anton de Souza, Daniela Rosa, Antonio LuiZ Frasson, Felipe Pereira Zerwes, Nathalia Cunha Rossato, Patricia Asthon-Prolla, Sergio Simon, Jose Bines, Carlos Barrios, Alessandra Morelle, Carlos Alberto Sampaio Filho, Max Mano, Rafaela Gomes and Gustavo Werutsky.
Breast cancer in the Pan-American region: Inequities in incidence and mortality rates according to the human development index
Barrios CH, Werutsky G, Martínez-Mesa J.
Advanced stage at diagnosis and worse clinicopathologic features in young woman with breast cancer. A sub-analysis of Brazilian population through the AMAZONA III study (GBECAM 0115).
Maria Alice Franzoi, Daniela D. Rosa, Facundo Zaffaroni, Gustavo Werutsky, Sérgio Simon, José Bines, Carlos Barrios, Eduardo Cronemberger, Geraldo Silva Queiroz, Vladmir Cordeiro de Lima, Ruffo Freitas Júnior, José Couto, Karla Emerenciano, Heloísa Resende, Susanne Crocamo, Tomás Reinert, Brigitte Van Eyli, Yeni Nerón, Vanessa Dybal, Nicolas Lazaretti, Rita de Cassia Costamillan, Diocésio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Morelle, Carlos Alberto Sampaio Filho, Max Mano, Pedro E. R. Liedke
Generating Real World Data of Breast Cancer in Brazil: validation of AMAZONA III results with cancer registries
Gustavo Werutsky, Daniela Dornelles Rosa, Sergio D. Simon, José Bines, Carlos Sampaio, Alessandra Morelle, Eduardo Cronemberger, Geraldo Queiroz, Vanessa Nascimento, Rodrigo Rol, Rafaela Gomes, Carlos Barrios SBOC 2019; 87510, poster Full link: http://www.brazilianjournalofoncology.com.br/summary/15
Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study
Sergio Daniel Simon, José Bines, Gustavo Werutsky, João Soares Nunes, Fernando Chalu Pacheco, José Getúlio Segalla, Andrea J.S. Gomes, Brigitte Marie H.R. Adam Van Eyll, Daniel Luiz Gimenes, Susanne Crocamo, Ruffo Freitas-Junior, Lissandra Dal Lago, Geraldo Silva Queiroz, Sérgio Jobim de Azevedo, Daniela Dornelles Rosa, Gilson Delgado, Giuliano Santos Borges, Yeni Verônica do Nascimento, Facundo Zaffaroni, Jeovany Martínez-Mesa, Carlos H.E. Barrios
Locally advanced breast cancer in Brazil: current status and future perspectives
Gustavo Werutsky, Paulo Nunes and Carlos Barrios
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
Carlos Henrique Barrios, Tomás Reinert and Gustavo Werutsky